Literature DB >> 2502340

Autotransfusion in revision total hip arthroplasties using uncemented prostheses.

J K Law1, J D Wiedel.   

Abstract

During the period from March 1983 to April 1987, autotransfusion was used in 64 patients treated with cementless revision total hip arthroplasties. An average of 3.9 units of intraoperative blood was salvaged, using a semicontinuous system; 6.5 units were salvaged in patients requiring segmental grafting of the acetabulum and femur. Patients not requiring segmental grafting had only 2.1 units salvaged. The use of homologous banked blood in patients without stored autologous units available was almost three times that of patients with autologous blood. Autotransfusion in the form of autologous transfusions and intraoperative blood salvage accounted for 72% of the total blood requirements. The cell saver is most cost-effective in patients with femur and acetabular bone loss requiring segmental grafting. An autologous transfusion program is important in all patients in whom blood transfusions are expected.

Entities:  

Mesh:

Year:  1989        PMID: 2502340

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

2.  Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty.

Authors:  Nael Hawi; Daniel Oliver Kendoff; Udo Hessling; Carl Haasper; Thorsten Gehrke; Mustafa Citak
Journal:  Int Orthop       Date:  2014-05-11       Impact factor: 3.075

3.  Blood loss in patients for total knee arthroplasty.

Authors:  Hiroshi Fujimoto; Toshifumi Ozaki; Kohji Asaumi; Hisayoshi Kato; Keichiro Nishida; Yasuhiro Takahara; Nobuhiro Abe; Hajime Inoue
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-02-19       Impact factor: 4.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.